Ronald W. Clark
Department of Cardiovascular and Metabolic Diseases
Pfizer Global Research and Development
Eastern Point Road
Groton
USA
Name/email consistency: high
- Assessment of cholesteryl ester transfer protein inhibitors for interaction with proteins involved in the immune response to infection. Clark, R.W., Cunningham, D., Cong, Y., Subashi, T.A., Tkalcevic, G.T., Lloyd, D.B., Boyd, J.G., Chrunyk, B.A., Karam, G.A., Qiu, X., Wang, I.K., Francone, O.L. J. Lipid Res. (2010)
- Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action. Clark, R.W., Ruggeri, R.B., Cunningham, D., Bamberger, M.J. J. Lipid Res. (2006)
- Raising high-density lipoprotein with cholesteryl ester transfer protein inhibitors. Clark, R.W. Curr. Opin. Pharmacol (2006)









